Table 3.
Outcomes | STS a | All NETT | Difference | P valueb |
|
---|---|---|---|---|---|
% | % | %| Δ| | (95%CI) | ||
30day Mortality † | 5.6% | 3.6% | 2.0% | (−0.5% to 4.5%) | 0.113 |
Table 3b: Comparison of Outcomes After LVRS in STS Database Versus Non-High Risk NETT Subset | |||||
Outcomes | STS a |
Non-high
Risk NETT Subset |
Difference |
P
value b |
|
% | % | %| Δ| | (95%CI) | ||
30day Mortality † | 5.6% | 2.2% | 3.4% | (1.0% to 5.7%) | 0.005 |
Re-admit to ICU ‡ | 7.8% | 11.7% | 3.9% | (−8.8% to 1.0%) | 0.156 |
Sepsis ‡ | 1.9% | 2.5% | 0.6% | (−2.5% to 1.3%) | 0.544 |
Arrhythmia ‡ | 16.2% | 18.6% | 2.4% | (−7.5% to 2.6%) | 0.350 |
MI ‡ | 1.1% | 1.0% | 0.1% | (−1.3% to 1.4%) | 0.910 |
Ventilator>48hrs ‡ | 4.6% | 13.6% | 9.1% | (−12.7% to −5.4%) | <0.001 |
Re-intubation ‡ | 12.9% | 21.8% | 8.9% | (−13.8% to −3.9%) | <0.001 |
Table 3c: Comparison of Outcomes After LVRS in STS Database Versus NETT Subset with Upper-Lobe Predominant Disease & Low Exercise Tolerance | |||||
Outcomes | STS a |
NETT,
Upper Lobe Disease ↓Exercise Tolerance |
Difference |
P
value b |
|
% | % | %| Δ| | (95%CI) | ||
30day Mortality † | 5.6% | 1.4% | 4.2% | (1.4% to 7.0%) | 0.039 |
Missing STS observations excluded;
P values from chi-squared tests;
Referenced from Naunheim et al. 2006 ;
Referenced from Fishman et al. 2003